Loading clinical trials...
Loading clinical trials...
Phenotypic characterisation of MVP by echocardiography in families. Identification of genes involved in MVP.
After clinical identification of patients with MVP, doctors organize 1st degree relative familial screening. A comprehensive echocardiography was carried out along with clinical examination. All echo data were stored for off-line analysis by a sonographer in our Core-lab. Blood was sample at the time of echocardiography in adult patients for DNA analyses. Follow-up for mitral valve changes will be performed after 5 years.
Age
All ages
Sex
ALL
Healthy Volunteers
Yes
Brest University Hospital
Brest, France
Nantes University Hospital
Nantes, France
Rennes University Hospital
Rennes, France
Start Date
December 1, 2010
Primary Completion Date
December 1, 2021
Completion Date
December 1, 2021
Last Updated
August 30, 2021
1,000
ESTIMATED participants
Lead Sponsor
Nantes University Hospital
Collaborators
NCT07040774
NCT07384871
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions